Hoechst to acquire 10.27% stake in Aventis Pharma - MarketLine Financial Deals

Hoechst to acquire 10.27% stake in Aventis Pharma

Hoechst to acquire 10.27% stake in Aventis Pharma - MarketLine Financial Deals
Hoechst to acquire 10.27% stake in Aventis Pharma
Published Mar 22, 2010
4 pages — Published Mar 22, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Hoechst GmbH is planning to acquire a 10.27% stake in Aventis Pharma, Ltd.

  
Source:
Document ID
MA24433_100505
Country
Country
Country
Ticker
507458=IN
Ticker
532852=IN
Ticker
SAN=FR
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Hoechst to acquire 10.27% stake in Aventis Pharma" Mar 22, 2010. Alacra Store. Dec 03, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Hoechst-to-acquire-10-27-stake-in-Aventis-Pharma-2052-32383>
  
APA:
MarketLine Financial Deals. (2010). Hoechst to acquire 10.27% stake in Aventis Pharma Mar 22, 2010. New York, NY: Alacra Store. Retrieved Dec 03, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Hoechst-to-acquire-10-27-stake-in-Aventis-Pharma-2052-32383>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.